https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-01 / Curr. Opin. Mol. Ther. 2006 Feb;8(1):46-512006-02-01 00:00:002019-02-15 09:00:02Novel immunotherapeutic approaches to glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-01 / HBPD INT 2006 Feb;5(1):22-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-01 / HBPD INT 2006 Feb;5(1):22-72006-02-01 00:00:002019-02-15 09:17:43Recent advances in heat shock protein-based cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-672006-02-01 00:00:002020-06-23 09:36:57A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-82006-01-21 00:00:002019-02-15 08:38:17Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-18 / Vaccine 2006 Feb;24(7):887-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-18 / Vaccine 2006 Feb;24(7):887-962006-01-18 00:00:002019-02-15 08:37:42Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-18 / Immunobiology 2006;211(1-2):29-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-18 / Immunobiology 2006;211(1-2):29-362006-01-18 00:00:002019-02-15 08:44:42Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-702006-01-17 00:00:002019-02-15 09:19:51Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-432006-01-09 00:00:002019-02-15 09:15:17Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-05 / Breast Cancer Res. 2006;8(1):101
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-05 / Breast Cancer Res. 2006;8(1):1012006-01-05 00:00:002019-02-15 08:44:41Dendritic cell defects in patients with cancer: mechanisms and significance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Biol. Pharm. Bull. 2006 Jan;29(1):100-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Biol. Pharm. Bull. 2006 Jan;29(1):100-42006-01-01 00:00:002019-02-15 09:19:53Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma
